From 2013 to 2023, Portugal's blood grouping reagents market showed decreasing per capita values. The value was at $0.9 in 2023. Notably, the year-on-year decline from 2022 to 2023 was approximately 6.25%, while the average annual decline (CAGR) over the past five years was around 2.69%.
Future trends to watch include technological advancements, potential regulatory changes, and shifts in healthcare policies. These factors could influence market growth or further decline, warranting close monitoring by stakeholders and investors to adapt strategies accordingly.
| # | 13 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data | ||
| 2 | 2 United Kingdom | 1.64 | 2023 | View data | ||
| 3 | 3 Italy | 1.52 | 2023 | View data | ||
| 4 | 4 Greece | 1.35 | 2023 | View data | ||
| 5 | 5 Croatia | 1.01 | 2023 | View data | ||
| 6 | 6 Portugal | 0.9 | 2023 | |||
| 7 | 7 Hungary | 0.84 | 2023 | View data | ||
| 8 | 8 Belgium | 0.65 | 2023 | View data | ||
